ImmunoGen, Inc.: insider trading
392 trades by 31 directors, officers and 10% owners since 2009, from their SEC Form 4 and 5 filings.
Bought, 12 months
$0
0 purchases by 0 insiders
Sold, 12 months
$0
0 sales by 0 insiders
Bought, 3 months
$0
0 purchases
Sold, 3 months
$0
0 sales
Insider buying and selling by month
Open-market purchases and sales by value, last three years.
Insiders (31)
Each insider's latest direct holding and their open-market trades of the last 12 months, most recent first.
| Insider | Shares owned directly | Bought, 12 m | Sold, 12 m | Latest trade |
|---|---|---|---|---|
| Daniel CharSVP & CHIEF LEGAL OFFICER | 0 | — | — | |
| Dean J. MitchellDirector | 0 | — | — | |
| Helen M. ThackrayDirector | 0 | — | — | |
| Mark Alan GoldbergDirector | 0 | — | — | |
| Mark J. EnyedyCHIEF EXECUTIVE OFFICER, Director | 0 | — | — | |
| Michael VasconcellesEVP R&D & MEDICAL AFFAIRS | 0 | — | — | |
| Renee LentiniVP & PRIN ACCTG OFFICER | 0 | — | — | |
| Richard John WallaceDirector | 0 | — | — | |
| Stacy Ann CoenSVP & CHIEF BUSINESS OFFICER | 0 | — | — | |
| Stuart A. ArbuckleDirector | 0 | — | — | |
| Theresa WingroveSVP OF REGULATORY AFFAIRS | 0 | — | — | |
| Kristine PetersonDirector | 0 | — | — | |
| Stephen C. McCluskiDirector | 0 | — | — | |
| Anna BerkenblitSVP & CHIEF MEDICAL OFFICER | 113,935 | — | — | |
| Kristen Harrington-SmithSVP & CHIEF COMMERCIAL OFFICER | 25,000 | — | — | |
| Thomas RyllSVP, Technical Operations | 84,714 | — | — | |
| David G. FosterV.P.-Fin., Prin. Acctg. Off. | 38,274 | — | — | |
| Craig BarrowsExecutive VP, General Counsel | 145,275 | — | — | |
| Blaine H. McKeeEVP & Chief Business Officer | 5,230 | — | — | |
| Richard J. GregoryExecutive VP & CSO | 236,056 | — | — | |
| David Brannon JohnstonChief Financial Officer | 180,690 | — | — | |
| Daniel M. JuniusDirector | 184,987 | — | — | |
| Peter J. WilliamsVP, Business Development | 50,620 | — | — | |
| John LambertExecutive Vice President | 120,521 | — | — | |
| Charles Q. MorrisExecutive VP & CDO | 27,090 | — | — | |
| Nicole OnettoDirector | 0 | — | — | |
| Gregory D. PerryChief Financial Officer | 0 | — | — | |
| James J. O'LearyVice President | 0 | — | — | |
| Mitchel SayareDirector | 383,136 | — | — | |
| David Warren CarterDirector | 0 | — | — | |
| Howard H. PienDirector | 0 | — | — |
Trades#
The newest 300 trades.
| Traded | Insider | Trade | Shares | Price | Value | Owned after | Filing |
|---|---|---|---|---|---|---|---|
| filed | Mark Alan GoldbergDirector | Disposal to the company | -60,720 | — | — | 0 | Form 4 |
| filed | Stuart A. ArbuckleDirector | Disposal to the company | -5,381 | — | — | 0 | Form 4 |
| filed | Daniel CharSVP & CHIEF LEGAL OFFICER | Disposal to the company | -1,000 | — | — | 0 | Form 4 |
| filed | Renee LentiniVP & PRIN ACCTG OFFICER | Disposal to the company | -14,723 | — | — | 0 | Form 4 |
| filed | Dean J. MitchellDirector | Disposal to the company | -103,000 | — | — | 0 | Form 4 |
| filed | Theresa WingroveSVP OF REGULATORY AFFAIRS | Disposal to the company | -21,039 | — | — | 0 | Form 4 |
| filed | Richard John WallaceDirector | Disposal to the company | -10,000 | — | — | 0 | Form 4 |
| filed | Stacy Ann CoenSVP & CHIEF BUSINESS OFFICER | Disposal to the company | -73,274 | — | — | 0 | Form 4 |
| filed | Michael VasconcellesEVP R&D & MEDICAL AFFAIRS | Disposal to the company | -1,327 | — | — | 0 | Form 4 |
| filed | Mark J. EnyedyCHIEF EXECUTIVE OFFICER, Director | Disposal to the company | -584,397 | — | — | 0 | Form 4 |
| filed | Helen M. ThackrayDirector | Disposal to the company | -3,074 | — | — | 0 | Form 4 |
| filed | Renee LentiniVP & PRIN ACCTG OFFICER | Sell10b5-1 plan | -2,631 | $29.30 | $77 K | 14,723 | Form 4 |
| filed | Theresa WingroveSVP OF REGULATORY AFFAIRS | Sell10b5-1 plan | -12,027 | $29.30 | $352 K | 21,039 | Form 4 |
| filed | Stacy Ann CoenSVP & CHIEF BUSINESS OFFICER | Sell10b5-1 plan | -4,583 | $29.30 | $134 K | 73,274 | Form 4 |
| filed | Mark J. EnyedyCHIEF EXECUTIVE OFFICER, Director | Sell10b5-1 plan | -20,107 | $29.28 | $589 K | 584,397 | Form 4 |
| filed | Theresa WingroveSVP OF REGULATORY AFFAIRS | Option exercise10b5-1 plan | +29,640 | — | — | 33,066 | Form 4 |
| filed | Renee LentiniVP & PRIN ACCTG OFFICER | Option exercise10b5-1 plan | +8,435 | — | — | 17,354 | Form 4 |
| filed | Stacy Ann CoenSVP & CHIEF BUSINESS OFFICER | Option exercise10b5-1 plan | +14,350 | — | — | 77,857 | Form 4 |
| filed | Mark J. EnyedyCHIEF EXECUTIVE OFFICER, Director | Option exercise10b5-1 plan | +51,234 | — | — | 604,504 | Form 4 |
| filed | Theresa WingroveSVP OF REGULATORY AFFAIRS | Option exercise10b5-1 plan | +58,900 | $4.830 | $284 K | 62,326 | Form 4 |
| filed | Theresa WingroveSVP OF REGULATORY AFFAIRS | Option exercise10b5-1 plan | +2,667 | $5.750 | $15 K | 64,993 | Form 4 |
| filed | Theresa WingroveSVP OF REGULATORY AFFAIRS | Option exercise10b5-1 plan | +126,100 | $5.250 | $662 K | 191,093 | Form 4 |
| filed | Theresa WingroveSVP OF REGULATORY AFFAIRS | Sell10b5-1 plan | -187,667 | $29.64 | $5.6 M | 3,426 | Form 4 |
| filed | Stacy Ann CoenSVP & CHIEF BUSINESS OFFICER | Option exercise | +30,000 | $5.320 | $160 K | 63,140 | Form 4 |
| filed | Helen M. ThackrayDirector | Grant or award | +252 | $29.65 | $7 K | 3,074 | Form 4 |
| filed | Michael VasconcellesEVP R&D & MEDICAL AFFAIRS | Grant or award | +1,327 | $16.01 | $21 K | 1,327 | Form 4 |
| filed | Renee LentiniVP & PRIN ACCTG OFFICER | Grant or award | +467 | $16.01 | $7 K | 8,919 | Form 4 |
| filed | Stuart A. ArbuckleDirector | Grant or award | +442 | $29.65 | $13 K | 5,381 | Form 4 |
| filed | Theresa WingroveSVP OF REGULATORY AFFAIRS | Grant or award | +615 | $16.01 | $10 K | 3,426 | Form 4 |
| filed | Mark Alan GoldbergDirector | Grant or award | +569 | $29.65 | $17 K | 60,720 | Form 4 |
| filed | Stacy Ann CoenSVP & CHIEF BUSINESS OFFICER | Grant or award | +367 | $16.01 | $6 K | 63,507 | Form 4 |
| filed | Renee LentiniVP & PRIN ACCTG OFFICER | Sell10b5-1 plan | -6,548 | $29.74 | $195 K | 8,452 | Form 4 |
| filed | Renee LentiniVP & PRIN ACCTG OFFICER | Option exercise10b5-1 plan | +15,000 | — | — | 15,000 | Form 4 |
| filed | Theresa WingroveSVP OF REGULATORY AFFAIRS | Option exercise10b5-1 plan | +27,788 | $4.550 | $126 K | 30,599 | Form 4 |
| filed | Theresa WingroveSVP OF REGULATORY AFFAIRS | Option exercise10b5-1 plan | +89,657 | $5.320 | $477 K | 120,256 | Form 4 |
| filed | Theresa WingroveSVP OF REGULATORY AFFAIRS | Sell10b5-1 plan | -117,445 | $29.40 | $3.5 M | 2,811 | Form 4 |
| filed | Stacy Ann CoenSVP & CHIEF BUSINESS OFFICER | Sell10b5-1 plan | -3,826 | $29.20 | $112 K | 33,140 | Form 4 |
| filed | Kristine PetersonDirector | Option exercise10b5-1 plan | +10,000 | $10.10 | $101 K | 10,000 | Form 4 |
| filed | Kristine PetersonDirector | Option exercise10b5-1 plan | +10,000 | $13.07 | $131 K | 20,000 | Form 4 |
| filed | Kristine PetersonDirector | Sell10b5-1 plan | -20,000 | $28.90 | $578 K | 0 | Form 4 |
| filed | Theresa WingroveSVP OF REGULATORY AFFAIRS | Option exercise10b5-1 plan | +133,691 | $10.65 | $1.4 M | 136,502 | Form 4 |
| filed | Theresa WingroveSVP OF REGULATORY AFFAIRS | Option exercise10b5-1 plan | +30,733 | $10.79 | $332 K | 167,235 | Form 4 |
| filed | Theresa WingroveSVP OF REGULATORY AFFAIRS | Sell10b5-1 plan | -164,424 | $28.95 | $4.8 M | 2,811 | Form 4 |
| filed | Theresa WingroveSVP OF REGULATORY AFFAIRS | Option exercise10b5-1 plan | +6,792 | $10.65 | $72 K | 9,603 | Form 4 |
| filed | Theresa WingroveSVP OF REGULATORY AFFAIRS | Sell10b5-1 plan | -6,792 | $16.66 | $113 K | 2,811 | Form 4 |
| filed | Stacy Ann CoenSVP & CHIEF BUSINESS OFFICER | Option exercise10b5-1 plan | +2,200 | $4.920 | $11 K | 39,166 | Form 4 |
| filed | Stacy Ann CoenSVP & CHIEF BUSINESS OFFICER | Option exercise10b5-1 plan | +76,023 | $7.690 | $585 K | 115,189 | Form 4 |
| filed | Stacy Ann CoenSVP & CHIEF BUSINESS OFFICER | Sell10b5-1 plan | -78,223 | $16.05 | $1.3 M | 36,966 | Form 4 |
| filed | Stacy Ann CoenSVP & CHIEF BUSINESS OFFICER | Option exercise10b5-1 plan | +3,200 | $4.920 | $16 K | 40,166 | Form 4 |
| filed | Stacy Ann CoenSVP & CHIEF BUSINESS OFFICER | Option exercise10b5-1 plan | +900 | $7.690 | $7 K | 41,066 | Form 4 |
| filed | Stacy Ann CoenSVP & CHIEF BUSINESS OFFICER | Sell10b5-1 plan | -4,100 | $16.01 | $66 K | 36,966 | Form 4 |
| filed | Stacy Ann CoenSVP & CHIEF BUSINESS OFFICER | Option exercise10b5-1 plan | +20,986 | $4.920 | $103 K | 57,952 | Form 4 |
| filed | Theresa WingroveSVP OF REGULATORY AFFAIRS | Option exercise10b5-1 plan | +166,725 | $4.550 | $759 K | 169,536 | Form 4 |
| filed | Stacy Ann CoenSVP & CHIEF BUSINESS OFFICER | Option exercise10b5-1 plan | +5,300 | $7.690 | $41 K | 63,252 | Form 4 |
| filed | Theresa WingroveSVP OF REGULATORY AFFAIRS | Sell10b5-1 plan | -166,725 | $15.85 | $2.6 M | 2,811 | Form 4 |
| filed | Stacy Ann CoenSVP & CHIEF BUSINESS OFFICER | Sell10b5-1 plan | -26,286 | $16.01 | $421 K | 36,966 | Form 4 |
| filed | Richard John WallaceDirector | Option exercise | +10,000 | $14.70 | $147 K | 10,000 | Form 4 |
| filed | Theresa WingroveSVP OF REGULATORY AFFAIRS | Option exercise10b5-1 plan | +19,517 | $10.65 | $208 K | 22,328 | Form 4 |
| filed | Theresa WingroveSVP OF REGULATORY AFFAIRS | Sell10b5-1 plan | -19,517 | $16.66 | $325 K | 2,811 | Form 4 |
| filed | Renee LentiniVP & PRIN ACCTG OFFICER | Option exercise | +9,000 | $10.79 | $97 K | 108,017 | Form 4 |
| filed | Renee LentiniVP & PRIN ACCTG OFFICER | Option exercise | +2,619 | $2.680 | $7 K | 110,636 | Form 4 |
| filed | Renee LentiniVP & PRIN ACCTG OFFICER | Option exercise | +23,000 | $10.65 | $245 K | 133,636 | Form 4 |
| filed | Renee LentiniVP & PRIN ACCTG OFFICER | Option exercise | +14,373 | $5.250 | $75 K | 148,009 | Form 4 |
| filed | Renee LentiniVP & PRIN ACCTG OFFICER | Option exercise | +4,024 | $6.980 | $28 K | 152,033 | Form 4 |
| filed | Renee LentiniVP & PRIN ACCTG OFFICER | Option exercise | +55,550 | $7.690 | $427 K | 207,583 | Form 4 |
| filed | Renee LentiniVP & PRIN ACCTG OFFICER | Option exercise | +11,962 | $5.320 | $64 K | 219,545 | Form 4 |
| filed | Renee LentiniVP & PRIN ACCTG OFFICER | Sell | -219,545 | $15.29 | $3.4 M | 0 | Form 4 |
| filed | Mark Alan GoldbergDirector | Option exercise10b5-1 plan | +10,000 | $14.70 | $147 K | 70,151 | Form 4 |
| filed | Mark Alan GoldbergDirector | Option exercise10b5-1 plan | -10,000 | $15.08 | $151 K | 60,151 | Form 4 |
| filed | Theresa WingroveSVP OF REGULATORY AFFAIRS | Option exercise | +158,641 | $4.550 | $722 K | 161,452 | Form 4 |
| filed | Theresa WingroveSVP OF REGULATORY AFFAIRS | Option exercise | +33,363 | $4.550 | $152 K | 194,815 | Form 4 |
| filed | Theresa WingroveSVP OF REGULATORY AFFAIRS | Sell | -192,004 | $14.40 | $2.8 M | 2,811 | Form 4 |
| filed | Helen M. ThackrayDirector | Grant or award | +472 | $15.87 | $7 K | 2,822 | Form 4 |
| filed | Stuart A. ArbuckleDirector | Grant or award | +827 | $15.87 | $13 K | 4,939 | Form 4 |
| filed | Mark Alan GoldbergDirector | Grant or award | +1,063 | $15.87 | $17 K | 60,151 | Form 4 |
| filed | Dean J. MitchellDirector | Option exerciseamended | +10,000 | $14.70 | $147 K | 103,000 | Form 4/A |
| filed | Dean J. MitchellDirector | Option exercise | +10,000 | $14.70 | $147 K | 152,667 | Form 4 |
| filed | Theresa WingroveSVP OF REGULATORY AFFAIRS | Option exercise | +50,000 | $4.550 | $228 K | 136,156 | Form 4 |
| filed | Theresa WingroveSVP OF REGULATORY AFFAIRS | Option exercise | +33,334 | $3.050 | $102 K | 169,490 | Form 4 |
| filed | Theresa WingroveSVP OF REGULATORY AFFAIRS | Option exercise | +25,334 | $2.680 | $68 K | 194,824 | Form 4 |
| filed | Theresa WingroveSVP OF REGULATORY AFFAIRS | Sell | -192,013 | $15.44 | $3.0 M | 2,811 | Form 4 |
| filed | Kristine PetersonDirector | Option exercise10b5-1 plan | +10,000 | $14.70 | $147 K | 10,000 | Form 4 |
| filed | Stephen C. McCluskiDirector | Option exercise10b5-1 plan | +10,000 | $14.70 | $147 K | 10,000 | Form 4 |
| filed | Kristine PetersonDirector | Option exercise10b5-1 plan | -10,000 | $16.08 | $161 K | 0 | Form 4 |
| filed | Stephen C. McCluskiDirector | Option exercise10b5-1 plan | -10,000 | $16.05 | $161 K | 0 | Form 4 |
| filed | Renee LentiniPRIN. FIN & ACCTG. OFF. | Option exercise | +11,500 | $3.050 | $35 K | 85,376 | Form 4 |
| filed | Renee LentiniPRIN. FIN & ACCTG. OFF. | Option exercise | +9,832 | $4.550 | $45 K | 95,208 | Form 4 |
| filed | Renee LentiniPRIN. FIN & ACCTG. OFF. | Option exercise | +3,809 | $5.250 | $20 K | 99,017 | Form 4 |
| filed | Stacy Ann CoenSVP & CHIEF BUSINESS OFFICER | Option exercise | +26,006 | $7.690 | $200 K | 36,966 | Form 4 |
| filed | Stacy Ann CoenSVP & CHIEF BUSINESS OFFICER | Option exercise | +100,210 | $4.920 | $493 K | 111,170 | Form 4 |
| filed | Stacy Ann CoenSVP & CHIEF BUSINESS OFFICER | Sell | -100,210 | $14.20 | $1.4 M | 10,960 | Form 4 |
| filed | Stacy Ann CoenSVP & CHIEF BUSINESS OFFICER | Option exercise | +80,326 | $4.920 | $395 K | 91,286 | Form 4 |
| filed | Stacy Ann CoenSVP & CHIEF BUSINESS OFFICER | Sell | -80,326 | $17.05 | $1.4 M | 10,960 | Form 4 |
| filed | Mark J. EnyedyCHIEF EXECUTIVE OFFICER, Director | Option exercise | +782,240 | $5.250 | $4.1 M | 1.22 M | Form 4 |
| filed | Mark J. EnyedyCHIEF EXECUTIVE OFFICER, Director | Option exercise | +21,978 | $4.550 | $100 K | 1.25 M | Form 4 |
| filed | Mark J. EnyedyCHIEF EXECUTIVE OFFICER, Director | Option exercise | +300,000 | $5.650 | $1.7 M | 1.55 M | Form 4 |
| filed | Mark J. EnyedyCHIEF EXECUTIVE OFFICER, Director | Sell | -992,397 | $16.96 | $16.8 M | 553,270 | Form 4 |
| filed | Mark J. EnyedyCHIEF EXECUTIVE OFFICER, Director | Option exercise | +2,760 | $5.250 | $14 K | 444,209 | Form 4 |
| filed | Mark J. EnyedyCHIEF EXECUTIVE OFFICER, Director | Option exercise | +1.02 M | $4.550 | $4.6 M | 1.46 M | Form 4 |
| filed | Mark J. EnyedyCHIEF EXECUTIVE OFFICER, Director | Sell | -1.02 M | $16.61 | $16.9 M | 441,449 | Form 4 |
| filed | Renee LentiniPRIN. FIN & ACCTG. OFF. | Option exercise | +6,000 | $2.470 | $15 K | 28,843 | Form 4 |
| filed | Renee LentiniPRIN. FIN & ACCTG. OFF. | Option exercise | +28,652 | $2.310 | $66 K | 57,495 | Form 4 |
| filed | Renee LentiniPRIN. FIN & ACCTG. OFF. | Option exercise | +16,381 | $2.680 | $44 K | 73,876 | Form 4 |
| filed | Mark J. EnyedyCHIEF EXECUTIVE OFFICER, Director | Option exercise | +995,157 | $4.550 | $4.5 M | 1.44 M | Form 4 |
| filed | Renee LentiniPRIN. FIN & ACCTG. OFF. | Option exercise | +18,218 | $5.250 | $96 K | 41,061 | Form 4 |
| filed | Stacy Ann CoenSVP & CHIEF BUSINESS OFFICER | Option exercise | +4,255 | $4.920 | $21 K | 15,215 | Form 4 |
| filed | Mark J. EnyedyCHIEF EXECUTIVE OFFICER, Director | Sell | -986,521 | $17.45 | $17.2 M | 450,085 | Form 4 |
| filed | Stacy Ann CoenSVP & CHIEF BUSINESS OFFICER | Sell | -4,255 | $18.12 | $77 K | 10,960 | Form 4 |
| filed | Renee LentiniPRIN. FIN & ACCTG. OFF. | Option exercise | +40,348 | $2.310 | $93 K | 81,409 | Form 4 |
| filed | Mark J. EnyedyCHIEF EXECUTIVE OFFICER, Director | Sell | -8,636 | $18.15 | $157 K | 441,449 | Form 4 |
| filed | Renee LentiniPRIN. FIN & ACCTG. OFF. | Option exercise | +36,053 | $4.550 | $164 K | 117,462 | Form 4 |
| filed | Renee LentiniPRIN. FIN & ACCTG. OFF. | Option exercise | +23,751 | $6.980 | $166 K | 141,213 | Form 4 |
| filed | Renee LentiniPRIN. FIN & ACCTG. OFF. | Option exercise | +29,907 | $5.320 | $159 K | 171,120 | Form 4 |
| filed | Renee LentiniPRIN. FIN & ACCTG. OFF. | Sell | -148,277 | $17.55 | $2.6 M | 22,843 | Form 4 |
| filed | Theresa WingroveSVP OF REGULATORY AFFAIRS | Grant or award | +2,811 | $4.050 | $11 K | 86,156 | Form 4 |
| filed | Mark J. EnyedyCHIEF EXECUTIVE OFFICER, Director | Grant or award | +5,241 | $4.050 | $21 K | 441,449 | Form 4 |
| filed | Renee LentiniV.P.-FIN., PRIN. ACCTG. OFF. | Grant or award | +3,195 | $4.050 | $13 K | 22,843 | Form 4 |
| filed | Helen M. ThackrayDirector | Grant or award | +397 | $18.87 | $7 K | 2,350 | Form 4 |
| filed | Anna BerkenblitSVP & CHIEF MEDICAL OFFICER | Grant or award | +3,264 | $4.050 | $13 K | 113,935 | Form 4 |
| filed | Stuart A. ArbuckleDirector | Grant or award | +695 | $18.87 | $13 K | 4,112 | Form 4 |
| filed | Mark Alan GoldbergDirector | Grant or award | +894 | $18.87 | $17 K | 59,088 | Form 4 |
| filed | Stacy Ann CoenSVP & CHIEF BUSINESS OFFICER | Grant or award | +3,792 | $4.050 | $15 K | 10,960 | Form 4 |
| filed | Mark Alan GoldbergDirector | Grant or award | +4,394 | $3.840 | $17 K | 58,194 | Form 4 |
| filed | Helen M. ThackrayDirector | Grant or award | +1,953 | $3.840 | $7 K | 1,953 | Form 4 |
| filed | Stuart A. ArbuckleDirector | Grant or award | +3,417 | $3.840 | $13 K | 3,417 | Form 4 |
| filed | Theresa WingroveSVP OF REGULATORY AFFAIRS | Grant or award | +1,131 | $3.920 | $4 K | 83,345 | Form 4 |
| filed | Anna BerkenblitSVP & CHIEF MEDICAL OFFICER | Grant or award | +436 | $3.920 | $2 K | 110,671 | Form 4 |
| filed | Renee LentiniV.P.-FIN., PRIN. ACCTG. OFF. | Grant or award | +1,351 | $3.920 | $5 K | 19,648 | Form 4 |
| filed | Kristen Harrington-SmithSVP & CHIEF COMMERCIAL OFFICER | Option exercise | +25,000 | — | — | 25,000 | Form 4 |
| filed | Mark J. EnyedyCHIEF EXECUTIVE OFFICER, Director | Grant or award | +3,342 | $3.830 | $13 K | 436,208 | Form 4 |
| filed | Theresa WingroveSVP OF REGULATORY AFFAIRS | Grant or award | +2,645 | $3.830 | $10 K | 82,214 | Form 4 |
| filed | Stacy Ann CoenSVP & CHIEF BUSINESS OFFICER | Grant or award | +3,342 | $3.830 | $13 K | 7,168 | Form 4 |
| filed | Renee LentiniV.P.-FIN., PRIN. ACCTG. OFF. | Grant or award | +2,509 | $3.830 | $10 K | 18,297 | Form 4 |
| filed | Anna BerkenblitSVP & CHIEF MEDICAL OFFICER | Grant or award | +3,073 | $3.830 | $12 K | 110,235 | Form 4 |
| filed | Stacy Ann CoenSVP & Chief Business Officer | Grant or award | +1,496 | $5.600 | $8 K | 3,826 | Form 4 |
| filed | Anna BerkenblitSVP & Chief Medical Officer | Grant or award | +1,761 | $5.600 | $10 K | 107,162 | Form 4 |
| filed | Renee LentiniV.P.-Fin., Prin. Acctg. Off. | Grant or award | +1,957 | $5.600 | $11 K | 15,788 | Form 4 |
| filed | Theresa WingroveSVP of Regulatory Affairs | Grant or award | +2,051 | $5.600 | $11 K | 79,569 | Form 4 |
| filed | Dean J. MitchellDirector | Option exercise | +5,000 | $1.840 | $9 K | 15,000 | Form 4 |
| filed | Dean J. MitchellDirector | Option exercise | +10,000 | $4.640 | $46 K | 25,000 | Form 4 |
| filed | Dean J. MitchellDirector | Option exercise | +18,000 | $2.100 | $38 K | 43,000 | Form 4 |
| filed | Dean J. MitchellDirector | Option exercise | +50,000 | $4.560 | $228 K | 93,000 | Form 4 |
| filed | Theresa WingroveSVP of Regulatory Affairs | Grant or award | +1,768 | $5.520 | $10 K | 77,518 | Form 4 |
| filed | Stacy Ann CoenChief Business Officer | Grant or award | +2,330 | $5.520 | $13 K | 2,330 | Form 4 |
| filed | Renee LentiniV.P.-Fin., Prin. Acctg. Off. | Grant or award | +1,683 | $5.520 | $9 K | 13,831 | Form 4 |
| filed | Mark J. EnyedyChief Executive Officer, Director | Grant or award | +3,849 | $5.520 | $21 K | 432,866 | Form 4 |
| filed | Anna BerkenblitSVP & Chief Medical Officer | Grant or award | +2,062 | $5.520 | $11 K | 105,401 | Form 4 |
| filed | Thomas RyllSVP, Technical Operations | Grant or award | +3,849 | $5.520 | $21 K | 84,714 | Form 4 |
| filed | Theresa WingroveVP of Regulatory Affairs | Grant or award | +2,659 | $4.040 | $11 K | 75,750 | Form 4 |
| filed | Anna BerkenblitVP & Chief Medical Officer | Grant or award | +2,203 | $4.040 | $9 K | 103,339 | Form 4 |
| filed | David G. FosterV.P.-Fin., Prin. Acctg. Off. | Grant or award | +362 | $4.040 | $1 K | 38,274 | Form 4 |
| filed | David G. FosterV.P.-Fin., Prin. Acctg. Off. | Option exercise | +27,240 | — | — | 48,964 | Form 4 |
| filed | David G. FosterV.P.-Fin., Prin. Acctg. Off. | Sell10b5-1 plan | -11,052 | $6.380 | $71 K | 37,912 | Form 4 |
| filed | Mark J. EnyedyChief Executive Officer, Director | Gift | -10,000 | — | — | 429,017 | Form 4 |
| filed | David G. FosterV.P.-Fin., Prin. Acctg. Off. | Grant or award | +342 | $3.910 | $1 K | 21,724 | Form 4 |
| filed | Mark J. EnyedyChief Executive Officer, Director | Grant or award | +5,241 | $3.910 | $20 K | 439,017 | Form 4 |
| filed | Anna BerkenblitVP & Chief Medical Officer | Grant or award | +3,047 | $3.910 | $12 K | 101,136 | Form 4 |
| filed | Thomas RyllVP, Technical Operations | Grant or award | +5,241 | $3.910 | $20 K | 80,865 | Form 4 |
| filed | Theresa WingroveVP of Regulatory Affairs | Grant or award | +2,593 | $3.910 | $10 K | 73,091 | Form 4 |
| filed | David G. FosterV.P.-Fin., Prin. Acctg. Off. | Sell | -5,448 | $3.430 | $19 K | 21,382 | Form 4 |
| filed | David G. FosterV.P.-Fin., Prin. Acctg. Off. | Option exercise | +18,160 | — | — | 26,830 | Form 4 |
| filed | Craig BarrowsExecutive VP, General Counsel | Sell10b5-1 plan | -16,492 | $4.990 | $82 K | 145,275 | Form 4 |
| filed | Theresa WingroveSVP of Regulatory Affairs | Sell10b5-1 plan | -16,147 | $4.990 | $81 K | 70,498 | Form 4 |
| filed | Anna BerkenblitSVP & Chief Medical Officer | Sell10b5-1 plan | -25,803 | $4.990 | $129 K | 98,089 | Form 4 |
| filed | Mark J. EnyedyChief Executive Officer, Director | Sell10b5-1 plan | -55,222 | $4.990 | $276 K | 433,776 | Form 4 |
| filed | Thomas RyllSVP, Technical Operations | Sell10b5-1 plan | -16,790 | $4.990 | $84 K | 75,624 | Form 4 |
| filed | Theresa WingroveVP of Regulatory Affairs | Grant or award | +4,762 | $1.990 | $9 K | 86,645 | Form 4 |
| filed | David G. FosterV.P.-Fin., Prin. Acctg. Off. | Grant or award | +662 | $1.990 | $1 K | 8,670 | Form 4 |
| filed | Mark J. EnyedyChief Executive Officer, Director | Grant or award | +5,230 | $1.840 | $10 K | 488,998 | Form 4 |
| filed | David G. FosterV.P.-Fin., Prin. Acctg. Off. | Grant or award | +3,536 | $1.840 | $7 K | 8,008 | Form 4 |
| filed | Blaine H. McKeeEVP & Chief Business Officer | Grant or award | +5,230 | $1.840 | $10 K | 5,230 | Form 4 |
| filed | Craig BarrowsExecutive VP, General Counsel | Grant or award | +5,230 | $1.840 | $10 K | 161,767 | Form 4 |
| filed | Anna BerkenblitVP & Chief Medical Officer | Grant or award | +5,230 | $1.840 | $10 K | 123,892 | Form 4 |
| filed | Thomas RyllVP, Technical Operations | Grant or award | +5,230 | $1.840 | $10 K | 92,414 | Form 4 |
| filed | Richard J. GregoryExecutive VP & CSO | Sell10b5-1 plan | -3,038 | $5.270 | $16 K | 236,056 | Form 4 |
| filed | Thomas RyllVP, Technical Operations | Grant or award | +2,455 | $4.080 | $10 K | 98,679 | Form 4 |
| filed | Mark J. EnyedyChief Executive Officer, Director | Grant or award | +2,455 | $4.080 | $10 K | 534,838 | Form 4 |
| filed | Theresa WingroveVP of Regulatory Affairs | Grant or award | +2,244 | $4.080 | $9 K | 92,915 | Form 4 |
| filed | Craig BarrowsExecutive VP, General Counsel | Grant or award | +2,455 | $4.080 | $10 K | 171,407 | Form 4 |
| filed | David G. FosterV.P.-Fin., Prin. Acctg. Off. | Grant or award | +1,472 | $4.080 | $6 K | 3,472 | Form 4 |
| filed | Anna BerkenblitVP & Chief Medical Officer | Grant or award | +2,455 | $4.080 | $10 K | 135,224 | Form 4 |
| filed | Mark Alan GoldbergDirector | Buy | +30,000 | $5.760 | $173 K | 53,800 | Form 4 |
| filed | Anna BerkenblitVP & Chief Medical Officer | Sell10b5-1 plan | -5,851 | $8.000 | $47 K | 132,769 | Form 4 |
| filed | Anna BerkenblitVP & Chief Medical Officer | Sell10b5-1 plan | -5,851 | $9.460 | $55 K | 138,620 | Form 4 |
| filed | David Brannon JohnstonChief Financial Officer | Option exercise | +10,000 | $3.050 | $31 K | 190,690 | Form 4 |
| filed | David Brannon JohnstonChief Financial Officer | Sell | -10,000 | $11.02 | $110 K | 180,690 | Form 4 |
| filed | Daniel M. JuniusDirector | Option exercise | +25,000 | $4.290 | $107 K | 209,987 | Form 4 |
| filed | Daniel M. JuniusDirector | Sell | -25,000 | $12.02 | $301 K | 184,987 | Form 4 |
| filed | David Brannon JohnstonChief Financial Officer | Option exercise | +10,000 | $3.050 | $31 K | 190,690 | Form 4 |
| filed | David Brannon JohnstonChief Financial Officer | Sell | -10,000 | $11.53 | $115 K | 180,690 | Form 4 |
| filed | Craig BarrowsExecutive VP, General Counsel | Sell10b5-1 plan | -14,870 | $5.600 | $83 K | 156,537 | Form 4 |
| filed | Anna BerkenblitVP & Chief Medical Officer | Sell10b5-1 plan | -16,562 | $5.600 | $93 K | 118,662 | Form 4 |
| filed | Mark J. EnyedyChief Executive Officer, Director | Sell10b5-1 plan | -51,070 | $5.600 | $286 K | 483,768 | Form 4 |
| filed | Richard J. GregoryExecutive VP & CSO | Sell10b5-1 plan | -36,643 | $5.600 | $205 K | 199,413 | Form 4 |
| filed | Thomas RyllVP, Technical Operations | Sell10b5-1 plan | -11,495 | $5.600 | $64 K | 87,184 | Form 4 |
| filed | Theresa WingroveVP of Regulatory Affairs | Sell10b5-1 plan | -11,032 | $5.600 | $62 K | 81,883 | Form 4 |
| filed | Richard J. GregoryExecutive VP & CSO | Sell10b5-1 plan | -34,486 | $10.88 | $375 K | 239,094 | Form 4 |
| filed | Thomas RyllVP, Technical Operations | Sell10b5-1 plan | -11,876 | $10.88 | $129 K | 96,224 | Form 4 |
| filed | Craig BarrowsExecutive VP, General Counsel | Sell10b5-1 plan | -15,498 | $10.88 | $169 K | 168,952 | Form 4 |
| filed | Daniel M. JuniusDirector | Sell | -11,713 | $12.00 | $141 K | 184,987 | Form 4 |
| filed | David Brannon JohnstonChief Financial Officer | Sell10b5-1 plan | -21,060 | $10.87 | $229 K | 180,690 | Form 4 |
| filed | Theresa WingroveVP of Regulatory Affairs | Sell10b5-1 plan | -11,379 | $10.88 | $124 K | 90,671 | Form 4 |
| filed | Mark J. EnyedyChief Executive Officer, Director | Sell10b5-1 plan | -67,717 | $10.87 | $736 K | 532,383 | Form 4 |
| filed | Anna BerkenblitVP & Chief Medical Officer | Sell10b5-1 plan | -17,329 | $10.88 | $189 K | 144,471 | Form 4 |
| filed | Daniel M. JuniusDirector | Sell | -25,000 | $11.68 | $292 K | 196,700 | Form 4 |
| filed | Daniel M. JuniusDirector | Option exercise | +25,000 | $4.290 | $107 K | 221,700 | Form 4 |
| filed | Daniel M. JuniusDirector | Option exercise | +46,667 | $3.300 | $154 K | 243,367 | Form 4 |
| filed | Daniel M. JuniusDirector | Sell | -46,667 | $10.01 | $467 K | 196,700 | Form 4 |
| filed | Richard J. GregoryExecutive VP & CSO | Sell10b5-1 plan · amended | -2,904 | $6.640 | $19 K | 273,577 | Form 4/A |
| filed | Craig BarrowsExecutive VP, General Counsel | Option exerciseamended | +30,000 | $4.500 | $135 K | 206,900 | Form 4/A |
| filed | Craig BarrowsExecutive VP, General Counsel | Sellamended | -22,450 | $6.730 | $151 K | 184,450 | Form 4/A |
| filed | Craig BarrowsExecutive VP, General Counsel | Option exercise | +30,000 | $4.500 | $135 K | 66,500 | Form 4 |
| filed | Craig BarrowsExecutive VP, General Counsel | Sell | -22,450 | $6.730 | $151 K | 44,050 | Form 4 |
| filed | Craig BarrowsExecutive VP, General Counsel | Option exerciseamended | +20,000 | $4.500 | $90 K | 191,500 | Form 4/A |
| filed | Craig BarrowsExecutive VP, General Counsel | Sellamended | -14,600 | $6.950 | $101 K | 176,900 | Form 4/A |
| filed | Anna BerkenblitVP & Chief Medical Officer | Sell | -1,500 | $7.000 | $11 K | 161,800 | Form 4 |
| filed | Craig BarrowsExecutive VP, General Counsel | Option exercise | +20,000 | $4.500 | $90 K | 51,100 | Form 4 |
| filed | Craig BarrowsExecutive VP, General Counsel | Sell | -14,600 | $6.950 | $101 K | 36,500 | Form 4 |
| filed | Peter J. WilliamsVP, Business Development | Grant or award | +2,000 | $2.570 | $5 K | 50,620 | Form 4 |
| filed | Theresa WingroveVP of Regulatory Affairs | Grant or award | +102,050 | $2.470 | $252 K | 102,050 | Form 4 |
| filed | Anna BerkenblitVP & Chief Medical Officer | Grant or award | +157,300 | $2.470 | $389 K | 163,300 | Form 4 |
| filed | David Brannon JohnstonChief Financial Officer | Grant or award | +191,750 | $2.470 | $474 K | 201,750 | Form 4 |
| filed | Richard J. GregoryExecutive VP & CSO | Grant or award | +237,250 | $2.470 | $586 K | 276,481 | Form 4 |
| filed | Craig BarrowsVice-President,General Counsel | Grant or award | +140,400 | $2.470 | $347 K | 171,500 | Form 4 |
| filed | Peter J. WilliamsVP, Business Development | Grant or award | +48,620 | $2.470 | $120 K | 48,620 | Form 4 |
| filed | Mark J. EnyedyChief Executive Officer, Director | Grant or award | +500,000 | $2.470 | $1.2 M | 600,100 | Form 4 |
| filed | Richard J. GregoryExecutive VP & CSO | Sell10b5-1 plan | -2,904 | $6.640 | $19 K | 273,577 | Form 4 |
| filed | Mark Alan GoldbergDirector | Buy | +20,000 | $1.800 | $36 K | 23,800 | Form 4 |
| filed | Mark J. EnyedyChief Executive Officer, Director | Buy | +25,000 | $1.830 | $46 K | 100,100 | Form 4 |
| filed | Craig BarrowsVice-President,General Counsel | Buy | +10,000 | $1.710 | $17 K | 31,100 | Form 4 |
| filed | John LambertExecutive Vice President | Buy | +2,775 | $1.690 | $5 K | 120,521 | Form 4 |
| filed | Richard J. GregoryExecutive VP & CSO | Buy | +16,600 | $1.780 | $30 K | 39,231 | Form 4 |
| filed | David Brannon JohnstonChief Financial Officer | Buy | +10,000 | $1.700 | $17 K | 10,000 | Form 4 |
| filed | Daniel M. JuniusDirector | Option exercise | +27,085 | $3.190 | $86 K | 196,700 | Form 4 |
| filed | John LambertExecutive Vice President | Option exercise | +3,889 | $3.190 | $12 K | 110,746 | Form 4 |
| filed | John LambertExecutive Vice President | Option exercise | +7,000 | $5.770 | $40 K | 117,746 | Form 4 |
| filed | John LambertExecutive Vice President | Option exercise10b5-1 plan | +3,889 | $3.190 | $12 K | 110,746 | Form 4 |
| filed | John LambertExecutive Vice President | Sell10b5-1 plan | -3,889 | $8.220 | $32 K | 106,857 | Form 4 |
| filed | Richard J. GregoryExecutive VP & CSO | Sell10b5-1 plan | -2,369 | $11.10 | $26 K | 22,631 | Form 4 |
| filed | John LambertExecutive Vice President | Option exercise10b5-1 plan | +3,889 | $3.190 | $12 K | 110,746 | Form 4 |
| filed | Daniel M. JuniusChief Executive Officer, Director | Option exercise10b5-1 plan | +5,416 | $3.190 | $17 K | 175,031 | Form 4 |
| filed | Daniel M. JuniusChief Executive Officer, Director | Sell10b5-1 plan | -5,416 | $13.17 | $71 K | 169,615 | Form 4 |
| filed | John LambertExecutive Vice President | Sell10b5-1 plan | -3,889 | $13.20 | $51 K | 106,857 | Form 4 |
| filed | Daniel M. JuniusChief Executive Officer, Director | Gift | -1,003 | — | — | 169,615 | Form 4 |
| filed | Daniel M. JuniusChief Executive Officer, Director | Option exercise10b5-1 plan | +5,416 | $3.190 | $17 K | 176,035 | Form 4 |
| filed | John LambertExecutive Vice President | Option exercise10b5-1 plan | +3,889 | $3.190 | $12 K | 110,746 | Form 4 |
| filed | Daniel M. JuniusChief Executive Officer, Director | Sell10b5-1 plan | -5,416 | $13.11 | $71 K | 170,618 | Form 4 |
| filed | John LambertExecutive Vice President | Sell10b5-1 plan | -3,889 | $13.11 | $51 K | 106,857 | Form 4 |
| filed | Charles Q. MorrisExecutive VP & CDO | Sell10b5-1 plan | -5,170 | $14.00 | $72 K | 27,090 | Form 4 |
| filed | Dean J. MitchellDirector | Buy | +10,000 | $12.51 | $125 K | 10,000 | Form 4 |
| filed | Daniel M. JuniusChief Executive Officer, Director | Option exercise | +5,907 | $4.290 | $25 K | 170,618 | Form 4 |
| filed | John LambertExecutive Vice President | Option exercise10b5-1 plan | +3,889 | $3.190 | $12 K | 110,746 | Form 4 |
| filed | John LambertExecutive Vice President | Sell | -3,889 | $11.73 | $46 K | 106,857 | Form 4 |
| filed | Daniel M. JuniusChief Executive Officer, Director | Option exercise10b5-1 plan | +5,497 | $3.190 | $18 K | 165,309 | Form 4 |
| filed | Daniel M. JuniusChief Executive Officer, Director | Sell10b5-1 plan | -5,497 | $12.00 | $66 K | 159,812 | Form 4 |
| filed | Daniel M. JuniusChief Executive Officer, Director | Option exercise | +5,575 | $4.290 | $24 K | 159,690 | Form 4 |
| filed | Daniel M. JuniusChief Executive Officer, Director | Option exercise | +122 | $5.770 | $704 | 159,812 | Form 4 |
| filed | Daniel M. JuniusChief Executive Officer, Director | Option exercise10b5-1 plan | +5,335 | $3.190 | $17 K | 159,450 | Form 4 |
| filed | Daniel M. JuniusChief Executive Officer, Director | Sell | -5,335 | $12.01 | $64 K | 154,115 | Form 4 |
| filed | John LambertExecutive Vice President | Option exercise10b5-1 plan | +3,889 | $3.190 | $12 K | 110,746 | Form 4 |
| filed | John LambertExecutive Vice President | Sell | -3,889 | $9.550 | $37 K | 106,857 | Form 4 |
| filed | David Brannon JohnstonChief Financial Officer | Option exercise10b5-1 plan | +5,000 | $10.79 | $54 K | 5,000 | Form 4 |
| filed | David Brannon JohnstonChief Financial Officer | Sell | -5,000 | $15.00 | $75 K | 0 | Form 4 |
| filed | Daniel M. JuniusChief Executive Officer, Director | Option exercise | +4,899 | $5.770 | $28 K | 159,014 | Form 4 |
| filed | John LambertExecutive Vice President | Option exercise10b5-1 plan | +3,889 | $3.190 | $12 K | 110,746 | Form 4 |
| filed | Daniel M. JuniusChief Executive Officer, Director | Option exercise10b5-1 plan | +5,416 | $3.190 | $17 K | 159,531 | Form 4 |
| filed | John LambertExecutive Vice President | Sell | -3,889 | $13.16 | $51 K | 106,857 | Form 4 |
| filed | Daniel M. JuniusChief Executive Officer, Director | Sell | -5,416 | $13.15 | $71 K | 154,115 | Form 4 |
| filed | Daniel M. JuniusChief Executive Officer, Director | Option exercise | +12,310 | $5.770 | $71 K | 154,115 | Form 4 |
| filed | Daniel M. JuniusChief Executive Officer, Director | Option exercise10b5-1 plan | +5,416 | $3.190 | $17 K | 147,221 | Form 4 |
| filed | John LambertExecutive Vice President | Option exercise10b5-1 plan | +3,889 | $3.190 | $12 K | 110,746 | Form 4 |
| filed | David Brannon JohnstonChief Financial Officer | Option exercise10b5-1 plan | +5,000 | $10.79 | $54 K | 5,000 | Form 4 |
| filed | John LambertExecutive Vice President | Sell | -3,889 | $17.10 | $67 K | 106,857 | Form 4 |
| filed | David Brannon JohnstonChief Financial Officer | Sell | -5,000 | $17.04 | $85 K | 0 | Form 4 |
| filed | Daniel M. JuniusChief Executive Officer, Director | Sell | -5,416 | $17.03 | $92 K | 141,805 | Form 4 |
| filed | Daniel M. JuniusChief Executive Officer, Director | Option exercise10b5-1 plan | +5,416 | $3.190 | $17 K | 147,221 | Form 4 |
| filed | John LambertExecutive Vice President | Option exercise10b5-1 plan | +3,888 | $3.190 | $12 K | 110,745 | Form 4 |
| filed | Daniel M. JuniusChief Executive Officer, Director | Sell | -5,416 | $14.34 | $78 K | 141,805 | Form 4 |
| filed | John LambertExecutive Vice President | Sell | -3,888 | $14.34 | $56 K | 106,857 | Form 4 |
| filed | Nicole OnettoDirector | Option exercise | +3,211 | $7.820 | $25 K | 3,211 | Form 4 |
| filed | Nicole OnettoDirector | Sell | -3,211 | $13.86 | $45 K | 0 | Form 4 |
| filed | John LambertExecutive Vice President | Option exercise10b5-1 plan | +15,000 | $5.350 | $80 K | 121,857 | Form 4 |
| filed | John LambertExecutive Vice President | Sell | -15,000 | $11.78 | $177 K | 106,857 | Form 4 |
| filed | Daniel M. JuniusChief Executive Officer, Director | Option exercise | +1,215 | $5.740 | $7 K | 143,020 | Form 4 |
| filed | Daniel M. JuniusChief Executive Officer, Director | Sell | -1,215 | $8.020 | $10 K | 141,805 | Form 4 |
| filed | Daniel M. JuniusChief Executive Officer, Director | Option exercise | +10,647 | $5.740 | $61 K | 141,805 | Form 4 |
| filed | Daniel M. JuniusChief Executive Officer, Director | Option exercise10b5-1 plan | +35,315 | $5.740 | $203 K | 166,473 | Form 4 |
| filed | Daniel M. JuniusChief Executive Officer, Director | Sell | -35,315 | $8.360 | $295 K | 131,158 | Form 4 |
| filed | John LambertExecutive Vice President | Option exercise10b5-1 plan | +10,000 | $5.350 | $54 K | 116,857 | Form 4 |
| filed | John LambertExecutive Vice President | Sell | -10,000 | $8.320 | $83 K | 106,857 | Form 4 |
| filed | Daniel M. JuniusChief Executive Officer, Director | Option exercise | +6,969 | $5.740 | $40 K | 131,158 | Form 4 |
| filed | Daniel M. JuniusChief Executive Officer, Director | Option exercise | +26,132 | $5.740 | $150 K | 124,189 | Form 4 |
| filed | John LambertExecutive Vice President | Option exercise10b5-1 plan | +10,000 | $5.350 | $54 K | 116,857 | Form 4 |
| filed | John LambertExecutive Vice President | Sell | -10,000 | $8.740 | $87 K | 106,857 | Form 4 |
| filed | Charles Q. MorrisExecutive VP & CDO | Sell10b5-1 plan | -5,240 | $10.40 | $54 K | 32,260 | Form 4 |
| filed | Daniel M. JuniusChief Executive Officer, Director | Option exercise | +17,421 | $5.740 | $100 K | 98,057 | Form 4 |
| filed | Craig BarrowsVice-President,General Counsel | Option exercise | +15,000 | $3.300 | $50 K | 21,100 | Form 4 |
| filed | Daniel M. JuniusChief Executive Officer, Director | Option exercise | +15,000 | $5.740 | $86 K | 95,636 | Form 4 |
| filed | Daniel M. JuniusChief Executive Officer, Director | Sell | -15,000 | $16.40 | $246 K | 80,636 | Form 4 |
| filed | Charles Q. MorrisExecutive VP & CDO | Option exercise10b5-1 plan | +6,936 | $11.93 | $83 K | 44,436 | Form 4 |